NDRG2 and cancer: This study uncovered that metastatic tumor cells with a mesenchymal phenotype largely depend on glutamine utilization, with the gain of NDRG2 function using lentiviral expression abolishing the epithelial-mesenchymal transition and glutaminolysis in metastatic mucoepidermoid cancer (MC3) cells (235).